Want to join the conversation?
$XEL 2Q15 Call: XEL is reaffirming 2015 ongoing earnings guidance range of $2-2.15 per share. Pleased with the legislation passed in Minnesota and Texas during 2Q15. Company is confident of achieving goal of reducing the ROE gap by 50 BP by 2018. Growth projects are on schedule.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?